hashimoto's and glp 1 medication Does GLP-1 Help with Disease? Evidence Safety Microdosing GLP-1 for Hashimoto's: Evidence,

and Ray, P

Importantly, in most CVOTs the combined use of the two drug classes was not a prespecified endpoint

PP population included participants who completed NAC-treatment at full dosage (2 exclusions) beyond day 7 (8 exclusions), therefore considered exempt from major protocol deviation (PP: n = 13 in NAC- and 12 in placebo-group

Across animal models, GLP-1 receptor agonists consistently improved functional outcomes and produced marked reductions in infarct volume compared with placebo

This is an independent editorial assessment

877 Traditional Chinese medicine Jianpi-Tongluo Formula (JTF) effectively reduces joint edema and pain in OA rats, inhibits extracellular matrix degradation, and may work by inhibition of the NCOA4-HMGB1-GSK3-AQPs axis